Results 61 to 70 of about 1,692 (164)

An Exploration of the Views and Perspectives of Australian Trans and Gender Diverse Individuals About Transvaginal Ultrasound

Perspectives on Sexual and Reproductive Health, Volume 58, Issue 1, Page 77-90, March 2026.
ABSTRACT Background Transvaginal ultrasound (TVS) is used routinely in gynecological care in Australia to manage gynecological health concerns. Typically, TVS is well tolerated by patients, with low levels of discomfort reported. Trans and gender diverse people assigned female at birth may experience gender dysphoria or testosterone‐related anatomical ...
Caitlyn Wilke, Sav Zwickl, Jane Chalmers, Nayana Parange, Shae Maple, Sarah McMullen‐Roach   +5 more
wiley   +1 more source

Research Progress in the Treatment of Vaginitis With Bioactive Compounds: Targeting of Vaginal Microflora

MicrobiologyOpen, Volume 15, Issue 1, February 2026.
Mechanism diagram of the effect of herbal medicine on vaginitis. Herbal medicines mainly combat vaginitis by (A) inhibiting bacteria, (B) inhibiting fungi, (C) acting on the cilia of Trichomonas, (D) inhibiting virus replication, (E) repairing the mucosa, (F) enhancing immunity, and (G) maintaining the microecological balance.
Yongming Li, Huiyu Liu, Ruihan Li, Rong Li, Jiaqi Liu   +4 more
wiley   +1 more source

Probiotic‐Based Materials as Living Therapeutics

Advanced Materials, Volume 38, Issue 1, 2 January 2026.
Recent advances in Engineered Living Materials are highlighted, integrating synthetic biology and advanced materials, with a focus on probiotic‐based therapeutics. Probiotic Living Materials hold great potential for biosensing, infection treatment, osteogenesis, wound healing, vaginal and gastrointestinal disorders, and cancer therapy. breakthroughs in
Laura Sabio, Graham J. Day, Manuel Salmeron‐Sanchez   +2 more
wiley   +1 more source

Ospemifene efficacy and safety data in women with vulvovaginal atrophy

Gynecological Endocrinology, 2020
Vulvovaginal atrophy (VVA) is a frequent, underreported and underdiagnosed condition. Ospemifene is a third-generation Selective Estrogen Receptor Modulator (SERM) that has been shown to be effective in women with VVA and dyspareunia, vaginal dryness and vulvar vestibular symptoms.
Lino Del, Pup, Rafael, Sánchez-Borrego
openaire   +2 more sources

Effective correction of genitourinary menopausal syndrome by the method of fractional laser ablation [PDF]

РМЖ. Мать и дитя, 2018
Effective correction of genitourinary menopausal syndrome by the method of fractional laser ablation Dobrokhotova Yu.E., Ilyina I.Yu., Venediktova M.G., Utina M.S., Morozova K.V., Suvorova V.A., Vasilyeva A.S.
Yu.E. Dobrokhotova, Ilina I.Yu., Venediktova M.G., Utina M.S., Morozova K.V., Suvorova V.A., Vasilyeva A.S.   +6 more
doaj  

Treating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy

International Journal of Women's Health, 2009
SA Kingsberg¹, S Kellogg², M Krychman³1University Hospitals Case Medical Center, Case Western Reserve University Cleveland OH, USA; 2The Pelvic and Sexual Health Institute of Philadelphia, Drexel University College of Medicine,
SA Kingsberg, S Kellogg, M Krychman
doaj  

Non-hormonal therapies for vulvovaginal atrophy: Clinical cases

Гинекология
Menopause is associated with a deficiency of sex hormones, which significantly impacts a woman's physical and psycho-emotional state. In particular, the blood supply to the genitourinary system organs deteriorates, and the synthesis of connective tissue ...
Tatiana B. Motovilova, Liya Z. Sirotina, Oksana I. Trifonova, Irina A. Kruglova, Anastasiya D. Varnavskaya, Kseniia V. Kazakova   +5 more
doaj   +1 more source

Evaluation of cervical screening at treatment of a vulvovaginal atrophy in periand postmenopausal women [PDF]

Гинекология, 2016
Objective. Determination of effective application of vaginal complex estriol 0,2 mg/progesteron 2 mg/Lactobacillus casei rhamnosus 2¥109 at women with a vulvovaginal atrophy in peri-and postmenopausal women with a evaluation of cervical screening ...
T V Klinyshkova, I B Samosudova, O N Mironova   +2 more
doaj  

Safety and Efficacy of an Oxytocin Gel and an Equivalent Gel but Without Hormonal Ingredients (Vagivital® Gel) in Postmenopausal Women with Symptoms of Vulvovaginal Atrophy: A Randomized, Double-Blind Controlled Study

Medical Devices: Evidence and Research, 2020
Aino Fianu Jonasson,1 Marie Bixo,2 Inger Sundström Poromaa,3 Mikael Åstrom4 1Department of Clinical Sciences, Intervention and Technology, Division of Obstetrics and Gynecology, Karolinska Institute, Stockholm, Sweden; 2Department of Clinical ...
Fianu Jonasson A, Bixo M, Sundström Poromaa I, Åstrom M   +3 more
doaj  

Efficacy and safety of ultra-low-dose Vagifem (10 mcg)

Patient Preference and Adherence, 2011
Janet A Chollet1,2 1Beth Israel Deaconess Medical Center, Boston, MA, USA; 2Pear Tree Pharmaceuticals, Waltham, MA, USA Abstract: Vulvovaginal atrophy [VVA] is defined as inflammation of the vaginal epithelium due to atrophy secondary to decreased levels
Chollet JA
doaj